Pak seeks bigger SAARC to counter India's influence

October 12, 2016

Islamabad, Oct 12: Pakistan is exploring the possibility of creating a greater South Asian economic alliance to include China, Iran and neighbouring Central Asian republics as part of its bid counter India's influence in SAARC, a media report said today.pak

Dawn News, citing diplomatic observers, said Pakistan is exploring the possibility of creating a greater South Asian economic alliance to counter India's "controlling hold" on the eight-member South Asian Association for Regional Cooperation (SAARC).

A parliamentary delegation from Pakistan, which is now in New York, pitched this idea during its five-day visit to Washington last week, the report said.

"A greater South Asia is already emerging," Senator Mushahid Hussain Syed was quoted as saying in one of his interactions with the media.

"This greater South Asia includes China, Iran and the neighbouring Central Asian republics," he said.

He described the China-Pakistan Economic Corridor as the key economic route linking South Asia with Central Asia.

The Gwadar port, Syed said, would be the nearest warm water port, not only for China but also for the land-locked Central Asian states. "We want India to join this arrangement as well," said Syed.

Indians are "unlikely to accept" the offer as they are comfortable with the advantage that SAARC provides them, the report said.

"India used its influence in SAARC to isolate Pakistan when it announced that it would not attend the regional group's 19th summit, scheduled in Islamabad," the report said.

Citing continuous cross border terrorism by Pakistan, India had announced last month that "in the prevailing circumstances, the Indian government is unable to participate in the proposed Summit in Islamabad."

Besides India, four other SAARC members -- Bangladesh, Bhutan, Sri Lanka and Afghanistan -- had also pulled out of the summit.

"Among the eight SAARC nations, Afghanistan and Bangladesh are India's strong allies while Bhutan, surrounded by India from all sides, is too small to resist any move from New Delhi. The Maldives, Nepal and Sri Lanka have good ties with Pakistan, but they are not large enough to take on India," the report said.

The report cited that a senior diplomat had confirmed reports that Pakistan is actively seeking a new regional arrangement.

"Apparently, the showdown forced Pakistan to conclude that in its present shape, SAARC will always be dominated by India. That's why they are now talking about a greater South Asia," the diplomat was quoted as saying.

"Pakistan hopes that this new arrangement will give it more room to manoeuvre when India tries to force a decision on it," another diplomat said.

The report quoted diplomatic observers in Washington as saying that the proposed arrangement also suits China as it is also worried about India's rapidly growing influence in the region.

"They argue that China can play an important role in persuading Central Asian republics and Iran to join the new arrangement. But the observers warn that SAARC members will have little interest in supporting the idea," the report said.

"There is not much benefit for Bangladesh, Nepal and Sri Lanka in joining a land route far from their borders and Bangladesh and Sri Lanka have their own ports," it said.

The report stated thatt he member that is likely to get the most benefits from a greater South Asian alliance is Afghanistan, which is technically a land-locked Central Asian nation.

Any trade route that links South and Central Asian regions is good for Afghanistan, it noted.

"But observers believe that Afghanistan is too closely linked to India to join any arrangement that hurts India's interests. Afghanistan's presence in SAARC, however, justifies Pakistan's argument that Central Asian nations can be included in a greater South Asia.

Afghanistan applied for SAARC membership in 2006 and joined a year later, generating an interesting debate on the definition of South Asian identity because Afghanistan is a Central Asian country, the report said.

"But, as a South Asian diplomat pointed out, even if a greater South Asia became reality, there's no guarantee that its members would support Pakistan in its disputes with India," it said.

"Many Central Asian states have strong ties with India and Iran too has problems with Pakistan," the diplomat was quoted as saying.

Comments

Rikaz
 - 
Wednesday, 12 Oct 2016

India should not have cancelled this conference....

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 8,2020

New Delhi, Jan 8: Iran will welcome any peace initiative by India for de-escalating its tensions with the US after the killing of Iranian military commander Qasem Soleimani, the Iranian envoy here said on Wednesday.

His comments come hours after Iran launched missile strikes against two US military bases in Iraq in retaliation to the killing of its top commander General Qassem Soleimani.

"India usually plays a very good role in (maintaining) peace in the world. At the same time, India belongs to this region. We welcome all initiatives from all countries, especially India as a good friend for us, to not allow escalation (of tensions)," Iranian Ambassador to India Ali Chegeni told reporters after a condolence meeting for Solemani at the country's embassy here.

"We are not for war, we are looking for peace and prosperity for everybody in this region. We welcome any Indian initiative or any project that can help peace and prosperity in this world," he said.

On the Iranian attack on US targets in Iraq, Chegeni said his country retaliated under its right to defend.

Amid spiralling US-Iran tensions over the killing of Soleimani, External Affairs Minister S Jaishankar on Sunday had a conversation with his Iranian counterpart Javad Zarif and US Secretary of State Mike Pompeo, voicing India's concerns over the escalation of tensions.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

Washington, May 19: As the scientists across the world are struggling to develop a vaccine for combating coronavirus, US drugmaker Moderna announced on Monday (local time) that the phase I trial of its Covid-19 vaccine has shown positive early results.

The company is hopeful that it's vaccine could be available to the public as early as January next year. Several firms across the world are in the race to develop a vaccine for the deadly virus which has claimed over 3 lakh lives worldwide.

CNN citing Dr. Tal Zaks, Moderna's chief medical officer reported that "if future studies go well, the company's vaccine could be available to the public as early as January".

"This is absolutely good news and news that we think many have been waiting for for quite some time," Zaks was quoted as saying.

Moderna, based in Cambridge, Massachusetts announced that the vaccine developed neutralising antibodies to the virus at levels reaching or exceeding the levels seen in people who have naturally recovered from Covid-19, reported CNN.

These will be followed by phase 2 trials and phase 3 trials, which Moderna plans to start in July.

President Donald Trump had on Friday said that that the United States will be able to deliver a few hundred million doses of COVID-19 vaccine, under 'Operation Warp Speed', by the end of this year.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020 and we will do the best we can," Trump had said at a press conference at the White House on Friday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.